m 16209 has been researched along with tyrosine in 1 studies
Studies (m 16209) | Trials (m 16209) | Recent Studies (post-2010) (m 16209) | Studies (tyrosine) | Trials (tyrosine) | Recent Studies (post-2010) (tyrosine) |
---|---|---|---|---|---|
10 | 0 | 0 | 44,273 | 846 | 8,225 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hayashi, T; Inoue, G; Kato, K; Kohno, S; Kuzuya, H; Murakami, N; Nakao, K; Okamoto, M; Yoshimasa, Y | 1 |
1 other study(ies) available for m 16209 and tyrosine
Article | Year |
---|---|
Antihyperglycemic mechanism of M16209, an antidiabetic agent, in 3T3-L1 adipocytes.
Topics: 3T3 Cells; Adipocytes; Animals; Benzofurans; Biological Transport; CHO Cells; Cricetinae; Glucose; Glucose Transporter Type 1; Glucose Transporter Type 4; Hydantoins; Hypoglycemic Agents; Insulin; Insulin Receptor Substrate Proteins; Macromolecular Substances; Mice; Monosaccharide Transport Proteins; Muscle Proteins; Phosphoproteins; Phosphorylation; Receptor, Insulin; Signal Transduction; Tyrosine | 1997 |